A PHASE 1 HEALTHY VOLUNTEER DOSE ESCALATION STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF INTRAVENOUS HUMAN IGG1 FC-F241A (NVG-2089) FOR THE TREATMENT OF ITP
EHA Library, Greg Coffey,
4159661
STUDY DESIGN OF PHASE 3 PART IN A PHASE 2/3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SOVLEPLENIB IN WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA (ESLIM-02)
EHA Library, Bing Han,
4159673
GLOBAL, REGIONAL, AND NATIONAL BURDEN OF ACUTE MYELOID LEUKEMIA IN CHILDREN FROM 1990 TO 2021: A TEMPORAL TREND ANALYSIS BASED ON THE GLOBAL BURDEN OF DISEASE STUDY 2021
EHA Library, Xiaoli Chen,
4159709
PROSPECTIVE, OPEN-LABEL, PHASE I/III STUDY OF THE PHARMACOKINETICS, EFFICACY AND SAFETY OF A FIBRINOGEN CONCENTRATE FROM HUMAN PLASMA, FOR THE TREATMENT AND PROPHYLAXIS OF BLEEDING IN PATIENTS WITH CONGENITAL FIBRINOGEN DEFICIENCY
EHA Library, Heike Boehm,
4159667
GLOBAL, REGIONAL, AND NATIONAL BURDEN OF ACUTE LEUKEMIA AND ITS RISK FACTORS FROM 1990 TO 2021 AND PREDICTIONS TO 2040: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2021
EHA Library, Xinpu Han,
4159740